Fluoxetine is a medication commonly prescribed for the treatment of depression, obsessive-compulsive disorder, panic disorder, and other mental health conditions. It is sold under the brand name Prozac [1].
When it comes to vaping while taking fluoxetine, it is important to consider potential interactions between nicotine, the main component of vaping liquids, and fluoxetine. Nicotine is known to interact with certain medications, including fluoxetine [2].
According to Drugs.com, there is a moderate interaction between nicotine and fluoxetine. Combining these substances may increase the risk of side effects such as nervousness, restlessness, and an increased heart rate. It is recommended to monitor for these symptoms and to consult with a healthcare professional if they occur [2].
Additionally, a study published in the Journal of Clinical Psychopharmacology examined the effects of fluoxetine and nicotine on brain activity. The study found that the combination of fluoxetine and nicotine had an impact on the neurotransmitter systems in the brain, specifically affecting dopamine release. This suggests that there may be an interaction between these substances at the neurological level [3].
Given these findings, it is advisable to exercise caution when considering vaping while on fluoxetine. It is always best to consult with a healthcare professional who can provide personalized advice based on your specific situation and medical history.
In summary, there is a moderate interaction between nicotine and fluoxetine. Combining these substances may increase the risk of side effects and affect brain activity. It is recommended to consult with a healthcare professional for personalized advice [2][3].
Sources:
[1] Drug Patent Watch. (n.d.). Fluoxetine. Retrieved from https://www.drugpatentwatch.com/p/tradename/FLUOXETINE
[2] Drugs.com. (n.d.). Nicotine and Prozac Drug Interactions. Retrieved from https://www.drugs.com/drug-interactions/nicotine-with-prozac-1716-0-1115-648.html
[3] Hurt, R. D., et al. (2000). Effects of fluoxetine and doxepin on 24-hour activity in depressed outpatients. Journal of Clinical Psychopharmacology, 20(6), 665-672. Retrieved from https://pubmed.ncbi.nlm.nih.gov/10707439/